Page 24
23
• MA A Aged - full coverage, HCC or FFS • MA B Blind - full coverage, FFS • MA D Disabled – full coverage, HCC or FFS • MADW MEDWorks, Basic category – Medicaid for Employees with Disabilities; full coverage, HCC or FFS • MADI MEDWorks, medically improved category – Medicaid for Employees with Disabilities - full coverage, HCC or FFS • MA Q Refugee Medical Assistance (RMA) - full coverage, FFS • MA L Qualified Medicare Beneficiary (QMB) - limited coverage • MA J Specified Low-Income Medicare Beneficiary (SLMB) – limited coverage • MA I Qualified Individual (QI) – limited coverage • MA G Qualified Disabled Working (QDW) - limited coverage • MA10 Children birth through 18; HHW Package C, comprehensive coverage, some services subject to limits • MA E Family Planning Services for Women and Men – limited coverage, FFS. 2035.30.05 DETERMINATION OF MA 9 CATEGORY (MED 3) This category, established effective July 1, 1998, includes 141% - 158% of the Federal Poverty Level, and children aged 6 through 18 with income between 106% - 158% of the poverty level.23 The MA 9 income standards are listed in Section 3010.30.15. MA 9 is positioned in the hierarchy after MA 2 and before MA B and MA D. However, if a blind or disabled child is determined eligible for MA B or MA D, without a spend-down, she/he will be authorized in one of those categories not MA 9.
New applicants will be considered first in MA 9 without being required to go through the medical determination process with the MMRT. If they fail MA 9 eligibility, then they will be considered under MA B or MA D. Recipients who are eligible in the MA B or MA D categories without a spend-down, but who meet the MA 9 financial requirements will remain in MA B or MA D.
Recipient children in MA B or MA D who are in Medicaid certified facilities and who have liabilities will remain in those categories.
A child who meets the MA 9 requirements but would also be eligible for MA B or MA D with a spend-down, will be approved in MA 9.
2035.30.10 DETERMINATION OF MA 10 CATEGORY (MED 3)